Coverage at a glance
| Indication | Coverage |
|---|---|
| Obesity / chronic weight management (commercial, when benefit is elected) | Covered with prior authorization |
| Obesity / weight management (Humana Medicare Advantage) | Not covered |
Humana's commercial formulary includes Wegovy and Zepbound at Tier 3, but anti-obesity drug coverage is employer-elected. Many employers with Humana-administered plans have not elected the weight-management drug benefit. Humana Medicare Advantage does not cover either drug for weight loss, under the federal Medicare Part D obesity exclusion.
Source: Humana 2026 Prescription Drug Guide (PDF, updated 2026). Verified June 18, 2026.
Plan type: Commercial employer-sponsored plans (fully insured and self-funded).
What it costs once they say yes. With commercial insurance the manufacturer savings card takes Wegovy or Zepbound to as little as $25 a month. Your plan sets the copay before the card applies. What Wegovy costs with your plan. What Zepbound costs with your plan.
This varies by plan. About 64 percent of workers covered through Humana employer-sponsored plans are in self-funded plans, where the employer independently decides which drug benefits to include. Roughly 41 percent of employers exclude anti-obesity medications from their self-funded plan designs. The Humana standard commercial formulary would cover Wegovy and Zepbound with prior authorization, but your employer's plan document is what governs. Check your summary of benefits or call the number on your card (1-800-448-6262).
Coverage by indication
| BMI threshold | BMI 30 or higher, or BMI 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease) |
| Step therapy | Some plan designs require step therapy with Wegovy before Zepbound approval. The step requirement can be waived with documented contraindication or prior treatment failure. |
What the prior authorization needs:
- Your employer group must have elected the weight-management drug benefit
- Prior authorization is required
- BMI within the accepted threshold
- Documentation of a structured weight-management program for at least 6 months within the past 24 months
- Prescriber attestation that lifestyle modifications alone proved inadequate
- Ongoing reduced-calorie diet and increased physical activity while on therapy
Source: Humana 2026 Prescription Drug Guide (PDF, updated 2026). Official payer formulary guide (public URL confirmed, binary; tier placement and PA requirement confirmed; specific BMI PA criteria cross-checked against KFF commercial coverage analysis and published telehealth-platform PA experience). Verified June 18, 2026. This row is marked lower confidence: the policy document was confirmed at its public URL but served as an unreadable file, so the policy number and framework were cross-checked against secondary sources.
Humana Medicare Advantage (all plans) follows the Medicare Part D statutory exclusion under the Medicare Modernization Act of 2003, which prohibits Part D plans from covering drugs used solely for weight loss. This applies regardless of plan tier or formulary. Wegovy for established cardiovascular disease and Zepbound for moderate-to-severe sleep apnea may be covered under non-obesity indications when on the specific plan's drug list.
Source: Humana, Does Medicare cover weight-loss drugs? (Official Humana member resource page). Official payer member resource page (HTML, fetched directly). Verified June 18, 2026.
Medicare GLP-1 Bridge: The Medicare GLP-1 Bridge has been live since July 1, 2026 and runs through December 31, 2027. It is a CMS demonstration for Part D, not a Humana benefit. Eligible Part D members pay $50 for Wegovy and Foundayo in any form, plus the Zepbound KwikPen. Not the single-dose vials or pens, so the prescription has to say KwikPen. No plan has to sign up for it, but CMS sets clinical criteria and your doctor files a prior authorization. If you have type 2 diabetes, moderate-to-severe obstructive sleep apnea or noncirrhotic MASH, Part D can cover these drugs for that diagnosis, which rules you out of the Bridge.
Ozempic, Mounjaro and Rybelsus on Humana plans
Ozempic, Mounjaro and Rybelsus are approved for type 2 diabetes, not weight loss.
Does Humana cover Ozempic?
Yes, with prior approval. Humana pays for Ozempic once your prescriber gets the plan to sign off.
Humana's 2026 Medicare Part D drug lists cover Ozempic for type 2 diabetes, its only FDA-approved use. Prior authorization and a quantity limit of 3 per 28 days apply, and the tier depends on the plan, tier 3 on the Humana Premier Rx PDP that we cite here and lower on some other 2026 Humana lists. Neither list applies step therapy to Ozempic. Medicare does not cover weight-loss drugs, so Part D does not cover Ozempic for that use. Wegovy is the same semaglutide at a higher dose, approved for weight loss.
Medicare Part D. Verified August 27, 2026.
What Humana requires for Ozempic
What the prior authorization needs:
- Prior authorization (PA) required
- Quantity limit (QL): 3 per 28 days
- Tier 3 on the Humana Premier Rx PDP; tier 2 on Humana's 2026 Medicare Employer comprehensive drug list
Policy Y0040_PDG26_FINAL_5C_C. Source: Prescription Drug guide, Humana Premier Rx Plan (PDP), 2026 (updated 08/01/2026). formulary. Verified August 27, 2026.
Recent change: Humana updates its 2026 Part D drug lists during the plan year. The Premier Rx PDP list cited here was current as of August 2026 (updated 08/01/2026). Tier and rules can change, so verify against the current formulary for your plan.
Does Humana cover Mounjaro?
Yes on some plans. Humana publishes a different drug list for each plan it sells, so two people with the same insurer can get different answers.
Humana lists Mounjaro (tirzepatide) as a covered brand drug for type 2 diabetes on its 2026 Medicare Part D drug lists. Coverage terms vary by plan: on the Humana Value Rx Plan it sits on tier 3 with prior authorization and a quantity limit, while on the Humana Premier Rx Plan it is tier 3 with no prior authorization. Mounjaro is FDA-approved for type 2 diabetes only, and Medicare does not cover drugs used for weight loss, so it is not covered when prescribed to lose weight. The weight-loss version of the same tirzepatide is Zepbound, which Medicare Part D also does not cover.
Medicare Part D. Verified August 27, 2026.
What Humana requires for Mounjaro
What the prior authorization needs:
- Covered as a brand drug for type 2 diabetes on Humana's 2026 Medicare Part D drug lists.
- Prior authorization applies on some plans (for example, Humana Value Rx Plan, tier 3). Other plans cover it with no prior authorization (for example, Humana Premier Rx Plan, tier 3, and a Humana Medicare Employer Plan, tier 2).
- A quantity limit of about two to three pens per 28 days applies on plans that require prior authorization, such as the Humana Value Rx Plan.
- Tier ranges from tier 2 (preferred brand) to tier 3 (non-preferred brand) across the plans checked, so cost sharing depends on the plan.
- Not covered when prescribed for weight loss. Medicare does not cover drugs used for weight loss. The weight-loss form of the same tirzepatide is Zepbound, which Medicare Part D does not cover.
Policy Formulary 26400 (Y0040_PDG26_FINAL_3C_C). Source: Humana Value Rx Plan (PDP) 2026 Prescription Drug Guide, Formulary 26400. formulary. Verified August 27, 2026.
Does Humana cover Rybelsus?
Yes on some plans. Humana publishes a different drug list for each plan it sells, so two people with the same insurer can get different answers.
Humana is a Medicare plan, and some of its Part D drug lists cover Rybelsus for type 2 diabetes, but the tier and rules vary by plan. On 2026 plans that list it, such as HumanaChoice (PPO), Rybelsus sits on tier 3 with no prior authorization, step therapy, or quantity limit; some Humana employer plans place it on tier 2, and a few Part D drug lists (for example the Basic Rx and Value Rx PDPs) do not list it at all. Medicare does not cover Rybelsus for weight loss, and Rybelsus has no weight-loss indication. Wegovy is the semaglutide approved for weight loss.
Medicare Part D. Verified August 27, 2026.
What Humana requires for Rybelsus
What the prior authorization needs:
- Coverage and cost tier vary by the specific Humana Medicare plan.
- On 2026 plans that list Rybelsus it sits on tier 3 (HumanaChoice PPO) or tier 2 (Humana Medicare employer plan) with no prior authorization, step therapy, or quantity limit.
- Some Humana Part D drug lists, including the Basic Rx PDP and the Value Rx PDP, do not list Rybelsus at all.
- Members should confirm coverage on their own plan's drug list before filling.
Policy Y0040_PDG26_FINAL_15C_C. Source: 2026 Prescription Drug Guide, HumanaChoice (PPO) / Humana Value Choice (PPO), Humana Formulary (Y0040_PDG26_FINAL_15C_C, doc 20260015PDG2640826C, updated 08/01/2026). payer-formulary. Verified August 27, 2026. This row is marked lower confidence: the policy document was confirmed at its public URL but served as an unreadable file, so the policy number and framework were cross-checked against secondary sources.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Browse the prior-authorization letter library for a template that matches your plan and indication.
- Read the full coverage picture, denial reasons, and the four appeal pathways at GLP-1 insurance coverage.
- If the prior-authorization request is denied, the appeal letter library has templates by denial reason, covering peer-to-peer review, Level 1 and Level 2 internal appeal, and external review.
- Call the number on your insurance card and ask whether your specific plan includes the weight-management drug benefit before you submit.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time.
What it costs without insurance
The programs below bill you directly. Prices checked every Monday.
Frequently asked questions
Does Humana cover Wegovy and Zepbound?
Yes on some plans. Humana's commercial formulary includes Wegovy and Zepbound at Tier 3, but anti-obesity drug coverage is employer-elected. Many employers with Humana-administered plans have not elected the weight-management drug benefit. Humana Medicare Advantage does not cover either drug for weight loss, under the federal Medicare Part D obesity exclusion. This reflects the published policy verified June 2026.
What does Humana require to approve Wegovy and Zepbound?
For obesity / chronic weight management (commercial, when benefit is elected): The BMI requirement is BMI 30 or higher, or BMI 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease). Some plan designs require step therapy with Wegovy before Zepbound approval. The step requirement can be waived with documented contraindication or prior treatment failure.
Why might Humana deny Wegovy and Zepbound even if I meet the criteria?
About 64 percent of workers covered through Humana employer-sponsored plans are in self-funded plans, where the employer independently decides which drug benefits to include. Roughly 41 percent of employers exclude anti-obesity medications from their self-funded plan designs. The Humana standard commercial formulary would cover Wegovy and Zepbound with prior authorization, but your employer's plan document is what governs. Check your summary of benefits or call the number on your card (1-800-448-6262).
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Each page is built from a published payer policy document, government statute, or independent formulary analysis (KFF). Every indication row carries the source URL and the date we verified it. Where a payer's policy PDF was confirmed at its public URL but served as an unreadable binary, the policy number and coverage framework were cross-checked against secondary sources; those rows are marked lower confidence. Commercial coverage often depends on whether an employer elected the weight-management benefit. Those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
